Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01457469 · ClinicalTrials.gov registry record · Phase 1
Enhanced Quitline Intervention in Smoking Cessation for Patients With Non-Metastatic Lung Cancer
A Phase 1 study, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- Phase 1
- Development phase
- 6
- Enrollment target
NCT01457469 is a Phase 1 study that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 6 participants.
The verdict
NCT01457469, a Phase 1 study, has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 6 participants
- Enrollment target
Study Summary
This randomized clinical trial studies enhanced quitline intervention in smoking cessation for patients with non-metastatic lung cancer. Stop-smoking plans suggested by doctors may help patients with early-stage cancer quit smoking
Interventions
- OTHER questionnaire administration
- PROCEDURE quality-of-life assessment
- OTHER counseling intervention
- OTHER internet-based intervention
- BEHAVIORAL telephone-based intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2011-01 |
| Est. Completion | 2012-05 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01457469
The ClinicalTrials.gov registry entry for NCT01457469 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which questionnaire administration is the first listed.
NCT01457469 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01457469 about?
NCT01457469 is a clinical study titled "Enhanced Quitline Intervention in Smoking Cessation for Patients With Non-Metastatic Lung Cancer". This randomized clinical trial studies enhanced quitline intervention in smoking cessation for patients with non-metastatic lung cancer. Stop-smoking plans suggested by doctors may help patients with early-stage cancer quit smoking
What is the current status of trial NCT01457469?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 6 participants. The study started on 2011-01. Estimated completion is 2012-05.
What interventions are being tested in trial NCT01457469?
The interventions under investigation include: questionnaire administration (OTHER), quality-of-life assessment (PROCEDURE), counseling intervention (OTHER), internet-based intervention (OTHER), telephone-based intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT01457469?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.